256 related articles for article (PubMed ID: 6132791)
1. Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs.
Ohmiya Y; Angevine LS; Mehendale HM
Drug Metab Dispos; 1983; 11(1):25-30. PubMed ID: 6132791
[No Abstract] [Full Text] [Related]
2. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. II. Drug uptake into cells in vitro.
Heyneman CA; Reasor MJ
J Pharmacol Exp Ther; 1986 Jan; 236(1):60-4. PubMed ID: 3941401
[TBL] [Abstract][Full Text] [Related]
3. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels.
Heyneman CA; Reasor MJ
J Pharmacol Exp Ther; 1986 Jan; 236(1):55-9. PubMed ID: 3941400
[TBL] [Abstract][Full Text] [Related]
4. Recovery from chlorphentermine-induced phospholipidosis in rat alveolar macrophages: biochemical and cellular features.
Reasor MJ; Castranova V
Exp Mol Pathol; 1981 Dec; 35(3):359-69. PubMed ID: 6796431
[No Abstract] [Full Text] [Related]
5. Effect of chlorphentermine pretreatment on chlorphentermine uptake by isolated perfused rat lung.
Angevine LS; Ohmiya Y; Mehendale HM
Drug Metab Dispos; 1982; 10(1):68-73. PubMed ID: 6124387
[TBL] [Abstract][Full Text] [Related]
6. Chemiluminescence from rat alveolar macrophages following induction of phospholipidosis with chlorphentermine.
Reasor MJ; Koshut RA; McNulty MJ; Trush MA
Toxicol Appl Pharmacol; 1980 Mar; 52(3):497-506. PubMed ID: 7368220
[No Abstract] [Full Text] [Related]
7. Cytochemical demonstration of increased phospholipid content in cell membranes in chlorphentermine-induced phospholipidosis.
Coulombe PA; Bendayan M
J Histochem Cytochem; 1989 Feb; 37(2):139-47. PubMed ID: 2911004
[TBL] [Abstract][Full Text] [Related]
8. Chlorphentermine-induced phospholipidosis in rat alveolar macrophages--luminol-dependent chemiluminescence.
Reasor MJ
Biochem Pharmacol; 1981 Jan; 30(2):165-8. PubMed ID: 7236305
[No Abstract] [Full Text] [Related]
9. Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity.
Kacew S
J Pharmacol Exp Ther; 1985 Jan; 232(1):239-43. PubMed ID: 3965695
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary disposition and effects of drugs on pulmonary removal of endogenous substances.
Mehendale HM
Fed Proc; 1984 Aug; 43(11):2586-91. PubMed ID: 6204891
[TBL] [Abstract][Full Text] [Related]
11. Recovery from chlorphentermine-induced phospholipidosis in rat alveolar macrophages: morphological features.
Reasor MJ; Walker ER
Exp Mol Pathol; 1981 Dec; 35(3):370-9. PubMed ID: 7308413
[No Abstract] [Full Text] [Related]
12. Prevention of chlorphentermine-induced pulmonary phospholipidosis in rats by phenobarbital.
Reasor MJ; Davis ME
Drug Metab Dispos; 1985; 13(2):192-6. PubMed ID: 2859167
[TBL] [Abstract][Full Text] [Related]
13. Role of drug metabolism in protection against chlorphentermine-induced pulmonary phospholipidosis in adult rat.
Kacew S; Narbaitz R; Ruddick JA; Villeneuve DC
Exp Mol Pathol; 1981 Aug; 35(1):98-107. PubMed ID: 7250339
[No Abstract] [Full Text] [Related]
14. Effect of Hg2+ on accumulation and metabolism of chlorpromazine and imipramine in rat lungs.
Ohmiya Y; Mehendale HM
Drug Metab Dispos; 1984; 12(3):376-8. PubMed ID: 6145567
[No Abstract] [Full Text] [Related]
15. Role of age in amphiphilic drug-induced pulmonary morphological and metabolic responses.
Kacew S
Fed Proc; 1984 Aug; 43(11):2592-6. PubMed ID: 6146538
[TBL] [Abstract][Full Text] [Related]
16. Palmitic acid-1-14C incorporation and turnover in lung phospholipids of rats treated with chlorphentermine, RMI 10.393 and Ro 4-4318.
Karabelnik D; Zbinden G
Arch Toxicol; 1976 Jun; 35(3):163-74. PubMed ID: 989288
[TBL] [Abstract][Full Text] [Related]
17. Effect of chlorphentermine on the lipids of rat lungs.
Gloster J; Heath D; Hasleton P; Harris P
Thorax; 1976 Oct; 31(5):558-64. PubMed ID: 996817
[TBL] [Abstract][Full Text] [Related]
18. [Drug-induced phospholipidosis. An example of the use of NMR spectroscopy in pharmacologic research].
Blaschke G; Seydel JK; Wassermann O
Pharm Unserer Zeit; 1978 Jul; 7(4):105-14. PubMed ID: 684025
[No Abstract] [Full Text] [Related]
19. Effects of chlorphentermine and phentermine on the pulmonary disposition of 5-hydroxytryptamine in the rat in vivo.
Morita T; Mehendale HM
Am Rev Respir Dis; 1983 Jun; 127(6):747-50. PubMed ID: 6344705
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced phospholipidosis.
Lüllmann H; Lüllmann-Rauch R; Wassermann O
Ger Med; 1973; 3(3-4):128-35. PubMed ID: 4370610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
